Company / CapEx per Share
Lucid Diagnostics Inc. CapEx per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.08
FY2023
5-year range
$0.06 / $0.09
FY2021-FY2023
Trend
-13.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.06 to $0.08 over the past 2 years.
Based on SEC 10-K filings.
0.08 in FY2023.
Improved from $0.06 to $0.08 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, capex per share decreased 13.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0.08 | -13.8% |
| FY2022 | $0.09 | +50.1% |
| FY2021 | $0.06 | - |
As of FY2023 · SEC 10-K Annual Filings · Updated Jun 24, 2026